SlideShare a Scribd company logo
1
Presented by
Dr. Shrikant Sonune
Guided by
Dr Ashok Patil,
Dr Shilpa Kandalgaonkar,
Dr Mayur Chaudhary,
Dr Suyog Tupsakhare,
Dr Mahesh Gabhane.
Immunohistochemical
technique (part I)
 Histochemistry is a science that combines the techniques
of biochemistry and histology in the study of the chemical
constitution of tissues and cells.
 Immunology is a science that deals with the immune
system, cell-mediated and humoral aspects of immunity
and immune responses.
 Immunohistochemistry (IHC) is the integration of the
above mentioned disciplines.
 IHC utilizes antibodies and antibody based technology to
detect and localize specific tissue antigens.
 The basic principle of any IHC procedures is that an
antibody will specifically bind with an antigen to produce
an exclusive antibody-antigen complex.
 This bonding is used to visualize both normal and
diseased states of tissues.
 An antigen is a foreign substance that stimulates antibody
formation and has the ability to bind to an antibody.
 Antigens are commonly proteins or glycoproteins of high
molecular weight.
 Usually produce antibodies when administrated
parentally. (except some antigen like oral vaccines )
 Specificity is hallmark of immunologic reaction.
 2 attributes of antigenicity are
1. Introduction of immune response (immunogenicity)
2. Specific reaction with antibodies or sensitized cells
(immunological reactivity)
 Complete antigen
 Haptens incapable of inducing antibody formation by
themselves .
It can become immunogenic when combine with larger
molecule carrier.
 The site on an antigen to which a complementary
antibody may specifically react is called an epitope or
antigenic determinant.(considered as smallest unit of
antigenicity)
7
surface of the antigenepitope
antibody
 Consist of 4 to 5 amino acids
 Possessing
 Specific chemical structure
 Electric charge
 Special configuration
 Capable of sensitizing immunocytes
 May having primary sequence (linear epitope), tertiary
structure(folded structure).
 T –cells recognize sequential epitope.
 B- cells recognize tertiary epitope.
 The combining area on the antibody molecule is called
Paratopes
 An antibody is an immunoglobulin (Ig) capable of specific
combination with the antigen that caused its production.
 They are produced by plasma cells as a protection from
invasion of foreign substances such as bacteria, viruses,
etc.
 Antibodies are formed from plasma cells .
 Proteins of animal origin endowed with known antibody
activity & for certain other proteins related to them by
chemical structure.
 Synthesize by plasma cells & to some extent by
lymphocytes
 Immunoglobulin provides a structural & chemical concept
 While antibody is biological & functional concept.
 Each antibody consists of four polypeptides – two
identical heavy chains and two identical light chains
joined to form a "Y" shaped molecule.
9
heavy chains
light chains
 The classic Y shape of the antibody is composed of two
variable antigen-specific Fab “arms” and the constant Fc
“tail”.
Fab
10
Fc
 The amino acid sequence in the tips of the “arms" varies
among different antibodies. This variable region gives the
antibody its specificity for binding antigen.
variable region
11
 The constant region determines the mechanism used to
destroy antigen.
 Antibodies are divided into five major classes based
on this region’s structure and immune function.
12
constant region
 Antibodies can be divided into five major classes depending
on the structure of h-chain.
 The light chains of any antibody can be classified as either a
kappa or lambda type based on small polypeptide structural
differences.
Immunoglobulin class H- chains
IgG γ (gamma)
IgA α (alpha)
IgM µ (mu )
IgD (delta )
IgE (epsilon)
 The most commonly used antibody in IHC is of the IgG
class.
 Because it is the major class of immunoglobulin released
in serum.
 Major serum immunoglobulin
 80% of total
 Distributed equally in intravascular & extra vascular
compartments.
 Less carbohydrates
 Half life app 23 days
 Provides passive natural immunity in newborn.
 Sub-classes of IgG
IgG1 65
IgG2 23
IgG3 8
IgG4 4
 Second most abundant class.
 10 -13 %
 .6 – 4.2 mg / ml
 Half life 6 – 8 days
 2types
Secretory IgA
Serum IgA
Antibody-Antigen Reaction
15
 Antibodies bind to antigen through the variable regions of the
antibody.
 This bonding may be hydrophobic, ionic, Van der Waals or
hydrogen bonding.
 The strength of the binding of an antibody to a specific antigen
is called affinity.
 High affinity antibodies will bind larger amounts of antigen in a
given period of time, and can be used at higher dilutions.
16
 The rate of antigen-antibody reaction is affected by
 temperature
 pH of buffers
 diluents used in IHC procedures.
 Higher incubation temperature permits rapid antigen-
antibody binding.
 The buffer’s pH and ionic content can affect the charge of
amino acids in both the antibody and antigen.
17
18
 Antibodies are generated by immunizing (injecting)
animals with purified antigen.
 The animal responds by producing antibodies that
specifically recognize and bind to the antigen.
 Antibody reagents may be polyclonal or monoclonal.
19
Polyclonal Antibodies
20
 Polyclonal antibody reagents are produced as different
classes of immunoglobulins by many B-cells clones and
react with various epitopes on an antigen.
 They are more tolerant of small changes in the nature of
the antigen since they often recognize multiple epitopes.
 They may be generated in a variety of animals like rabbit,
goat, sheep, horse, etc.
 The rabbit is the most commonly used animal for
generating polyclonal antibodies.
21
22
Polyclonal antibodies reacting with various epitopes
Each antibody is made by a different B-cell
Polyclonal Antibody Production
23
A rabbit is injected (intradermally or subcutaneously) with
a purified dose of antigen.
24
antigen
The rabbit’s immune system responds by producing
antibodies specific to the injected antigen.
25
Y
Y
Y
antibodies
Blood is harvested from the ear at the peak of antibody
production.
26
Red blood cells and clotting proteins are removed and the
antiserum is purified.
Y
Y
Y
Y
Y
Y
27
 Polyclonal antibodies are purified either by Protein
Purification or Antigen Affinity Chromatography.
 Protein Purification eliminates the bulk of serum proteins
but does not eliminate nonspecific immunoglobulin
fraction.
 Antigen Affinity Purification eliminates the bulk of the
nonspecific immunoglobulin fraction using antigen to
capture the antibody leaving only the immunoglobulin of
desired specificity.
28
Monoclonal Antibodies
29
 Monoclonal antibodies are derived from a single B-cell and
are produced as a single class of immunoglobulin.
 They are raised by fusion of the specific B-cells with
immortal myeloma (B-cell) cancer cells to form a
hybridoma.
 A hybridoma can multiply indefinitely and continuously
produce a specific monoclonal antibody.
 They react with a specific epitope on a given antigen,
giving less background staining.
30
 Because they react with only one epitope, they are more
vulnerable to the loss of epitope through chemical
treatment of the antigen (e.g., fixation).
31
Monoclonal antibodies reacting with similar epitopes
32
Monoclonal Antibody Production
33
A mouse is injected (intradermally or subcutaneously) with
a purified dose of antigen.
antigen
34
The mouse’s immune system responds by producing
antibodies specific to the injected antigen.
Y
Y Y
antibodies
35
The antibody-producing B-cells are harvested from the
spleen or lymph nodes.
B-lymphocytes
spleen
36
The B-cells are fused with mouse myeloma cells forming
immortal hybrid cells or hybridomas.
myeloma cells
37
B-lymphocytes
The generated hybridomas will produce many copies of
the exact same antibody.
38
The hybridomas are either transplanted into the peritoneal
cavity of a syngeneic mouse and the antibodies produced are
harvested as ascitic fluid.
39
Or are propagated in a tissue culture medium and the antibodies
produced are harvested as a hybridoma supernatant
40
Primary Antibody
41
 Primary antibody refers to the antibody that is directed against
the antigen of interest.
 For example, CD20 can be used as the primary antibody to
demonstrate B-cells on a tissue section.
 Both polyclonal and monoclonal antibodies can be used as
primaries.
 They are typically supplied by manufacturers in two formats:
concentrated or ready-to-use (RTU).
42
 Manufacturers usually provide the user with a
recommended dilution range for concentrated antibodies.
 Concentrated antibodies are more economical to use but
has a disadvantage of requiring time and effort in initially
determining the optimal dilution.
 Ready To Use antibodies are convenient but the cost is
significantly greater than that of diluted concentrated
antibodies.
43
Antibody Titer and Dilution
44
 Titer is the highest dilution of the antibody resulting in strong
specific staining with the least amount of background.
 Background includes all nonspecific staining as a result of
procedural artifacts.
 Dilution is the ratio of the concentrated antibody to the total
volume of the desired.
 For example, a 1:5 dilution means one part concentrated
antibody and four parts diluent.
 Optimal working dilution is typically determined by titration or
dilution series.
45
1:8001:400
1:50 1:100 1:200
47
Chromogranin A antibody on pancreas
At 1:50, the Islet cells stain strongly but there is also a
strong background staining.
1:50
background staining
Islet cells
48
At 1:800, there is no background staining but the Islet cells
stain very weak.
1:800
49
At 1:200, there is good contrast and no background
staining, it is therefore the optimal working dilution.
1:200
50
51
Antibody Incubation Time
 Incubation time is inversely proportional to antibody
concentration.
 Higher concentration of antibody allows shorter incubation
time.
 It can be from minutes to hours, with 30-60 minutes the
most common practice.
52
53
Antibody Incubation Temperature
 Antibody-antigen reaction is hastened at 37C as
compared to room temperature.
 An increase in temperature also allows for a higher
dilution of the antibody.
 Humidity chambers must be used when incubating at
higher temperature to prevent drying of tissue sections.
54
Antigen Retrieval
55
 During the process of formalin fixation, many antigenic
sites are ‘masked’ and are therefore sometimes difficult or
impossible to stain without antigen retrieval.
 Antigen retrieval is a process of treating formalin fixed-
paraffin embedded tissue sections with proteolytic
enzymes or heating them in various buffer solutions in
order to expose the antigen.
 Commonly used proteolytic enzymes include trypsin,
pepsin and protease.
56
 Heat induced epitope retrieval (HIER) includes
microwaving, pressure cooking, steaming, autoclaving.
 Requires buffer of different concentrations and pH.
Commonly used buffers include
 Citrate at pH 6.0
 EDTA at pH 8.0
 Tris-HCL at pH 10.0
57
The staining results of CD3 antibody on tonsil, with and
without antigen retrieval.
No Antigen RetrievalCitrate buffer, pH 6.0
58
Enzymes and Chromogens
59
 Enzymes are proteins that act as catalysts to increase the
rate of chemical reaction.
 Detection systems attach enzyme labels to primary or
secondary antibodies to visualize the localized antibody-
antigen binding in tissue section.
60
 They are used in IHC to convert a colorless reagent into a
stable colored product (chromogen) that marks the site of
antibody-antigen complex.
 A chromogen is a substance that absorbs light, producing
color.
 Commonly used enzyme labels for IHC procedures
include
 horseradish peroxidase (HRP)
 alkaline phophatase (AP)
 HRP, from horseradish plant, is an enzyme that catalyze
the reduction of hydrogen peroxide (H2O2) to water and
oxygen.
 Commonly used chromogens for HRP include
 Amino ethylcarbazole (AEC)
 Diaminobenzidine (DAB)
61
 Amino ethylcarbazole is oxidized by HRP producing a
bright red reaction product.
 This reaction product is not stable and may fade over
time.
62
 Amino ethylcarbazole is soluble in alcohol,
 Stained slides should therefore be counterstained with
non-alcoholic hematoxylins (Mayer’s or Gills).
63
 Diaminobenzidine is oxidized by HRP producing a dark
brown reaction product.
 This reaction product is stable and does not fade over
time.
64
 Diaminobenzidine stained slides can be coverslipped with
permanent organic based mounting media.
 In some IHC procedures, the dark brown reaction product
can be modified and intensified by adding metals (copper
or cobalt) to Diaminobenzidine solution.
 Diaminobenzidine is not suited for staining melanoma
cases because the endogenous dark brown pigments in
tumor cells can be confused with DAB reaction product.
65
Staining results using AEC and Diaminobenzidine
chromogens.
AEC chromogen
Melanoma
DAB chromogen
Melanoma
66
IHC Staining Methods
67
The various IHC staining methods which can be used to
localize tissue antigens for light microscopy.
68
 Direct Method
 Two-Step Indirect Method
 Three-Step Indirect Method
 Peroxidase-Antiperoxidase (PAP) Method
 Alkaline-Antialkaline Phosphatase (APAAP) Method
 Avidin-Biotin Complex (ABC) Method
 Labeled Streptavidin-Biotin (LSAB) Method
69
Direct Method
70
 This method uses an enzyme-labeled primary antibody
with known antigenic specificity.
 Enzymes such as horseradish peroxidase (HRP) and
alkaline phosphatase (AP) are either conjugated to the
primary antibody.
 Less sensitive compared to other methods because it
produces little signal since only one enzyme-labeled
antibody is involved.
71
 Although rarely used nowadays, it has the advantages of
rapidity, ease of performance and limited nonspecific
reaction.
 Mostly used in fluorescent techniques where the primary
antibody is labeled with fluorescent compound (e.g.,
fluorescein isothiocyanate .
72
An enzyme-labeled primary antibody binds to the
tissue antigen.
73
enzyme
primary Ab
antigen
A substrate-chromogen solution is added producing a
colored end-product.
74
substrate-chromogen
Two-Step Indirect Method
75
 Uses an enzyme-labeled secondary antibody that is
directed against the unlabeled primary antibody.
 If the primary antibody (which is now the antigen) is made
in mouse, the secondary antibody must be against mouse
immunoglobulin.
 More sensitive than the Direct Method because several
secondary antibodies are likely to bind with a number of
various epitopes on the primary antibody increasing the
enzyme labels involved.
76
An unlabeled primary antibody binds to the tissue
antigen.
77
primary Ab (mouse)
antigen
An enzyme-labeled secondary antibody binds to the
primary antibody.
78
secondary Ab
(rabbit anti-mouse)
enzyme
A substrate-chromogen solution is added producing a
colored end-product.
79
substrate-chromogen
 Only one secondary antibody is shown bound to the
primary antibody in the previous illustration.
 However, several secondary antibodies are likely to bind
with various epitopes on the primary antibody, thus
increasing the signal.
80
Three-Step Indirect Method
81
 Uses another layer of enzyme-labeled (tertiary) antibody
that is added to the previously described Two-Step
Indirect Method.
 The added antibody layer increases signal and staining
intensity that is helpful when staining antigens with few or
limited available epitopes.
 Both secondary and tertiary antibodies must be
conjugated to the same enzyme.
82
An unlabeled primary antibody binds to the
tissue antigen.
83
antigen
primary Ab (mouse)
An enzyme-labeled secondary antibody binds to
the primary antibody.
84
secondary Ab
(rabbit anti-mouse)
enzyme
An enzyme-labeled tertiary antibody is added and binds to
the secondary antibody.
85
tertiary Ab
(goat anti-rabbit)
A substrate-chromogen solution is added producing a
colored end-product.
86
substrate-
chromogen
substrate-
chromogen
 Only one secondary antibody is shown bound to the
primary antibody in the previous illustration.
 However, several secondary antibodies are likely to bind
with different epitopes on the primary antibody, thus
increasing the signal.
87
Soluble Enzyme Immune
Complex Techniques
88
 These methods are among the sensitive IHC techniques,
attributed to more enzyme molecules being localized per
antigenic site.
 Methods include
 peroxidase-antiperoxidase (PAP)
 alkaline phosphatase-antialkaline phosphatase (APAAP)
 The secondary antibody must be directed against both the
primary and the antibody of the enzyme-antienzyme immune
complex.
89
 Preformed soluble enzyme-antienzyme immune complex
is prepared by mixing excess enzyme to its antibody.
90
antienzymeenzymes enzyme-antienzyme
immune complex
 The PAP immune complex consists of three molecules of
peroxidase and two antibodies.
 The APAAP immune complex consists of two molecules of
alkaline phosphatase and one antibody.
91
peroxidase-antiperoxidase complex alkaline phosphatase-antialkaline
phosphatase complex
Peroxidase-Antiperoxidase (PAP)
Method
93
An unlabeled primary antibody binds to the
tissue antigen.
94
primary Ab (mouse)
antigen
A secondary antibody binds to the primary
antibody.
95
secondary Ab
(rabbit anti-mouse)
A horseradish peroxidase-
mouse-antiperoxidase complex
is added and is bound by the
secondary antibody.
96
enzyme-antienzyme
immune complex
A substrate-chromogen solution
is added producing a colored
end-product.
97
substrate-chromogen
 Only one secondary antibody is shown bound to the
primary antibody in the previous illustration. However,
several secondary antibodies are likely to bind with
different epitopes on the primary antibody, thus increasing
the signal.
98
Avidin-Biotin Methods
99
 Uses the strong and high affinity of avidin (egg white
glycoprotein) for biotin (water-soluble vitamin).
 Avidin has four binding sites for biotin but fewer than
four molecules of biotin will actually bind to avidin.
100
avidin
biotin
molecules
 Two of the most common methods include
 Avidin-Biotin enzyme Complex (ABC)
 Labeled StreptAvidin-Biotin (LSAB)
 The inherent amplification of sensitivity offered by avidin
and biotin makes these methods more favorable than
PAP or APAAP.
 Streptavidin, a bacterial protein has recently replaced
avidin because it produces less background staining than
avidin.
101
Avidin-Biotin Enzyme Complex (ABC)
102
 The enzyme complex is prepared by mixing
biotinylated enzyme (HRP ) and avidin.
avidin-biotin-enzyme complex
103
 This preformed avidin-biotin-enzyme complex then reacts
with the biotinylated secondary antibody.
avidinbiotinylated
enzyme
An unlabeled primary antibody binds to the
antigen.
104
antigen primary Ab
(mouse)
A biotinylated secondary antibody binds to the
primary antibody.
105
secondary Ab
(rabbit anti-mouse)
biotin
A preformed avidin-biotin-enzyme complex solution is
added and binds to the biotinylated secondary
antibody.
106
avidin-biotin-enzyme complex
A substrate-chromogen solution is added
ending the reaction and producing a colored
end-product.
107
substrate-
chromogen
substrate-
chromogen
Labeled StreptAvidin-Biotin (LSAB)
108
 Uses enzyme-conjugated streptavidin. Streptavidin is
conjugated to several molecules of enzyme horseradish
peroxidase (HRP) or alkaline phosphatase (AP).
 The secondary antibody is conjugated to numerous biotin
molecules, each of which can potentially bind to an
enzyme-conjugated streptavidin.
109
An unlabeled primary antibody binds to tissue
antigen.
110
antigen
primary Ab
A biotinylated secondary
antibody binds to the primary
antibody.
Each secondary antibody
contains multiple biotin
molecules; several secondary
antibodies can bind to the
primary antibody.
111
biotin
secondary Ab
An enzyme-labeled streptavidin is added and binds
to the secondary antibody.
HRP-streptavidin
112
A substrate-chromogen solution is added producing
a colored end-product. substrate-
chromogen
113
114
Remove paraffin wax and hydrate tissue
section.
SPECIMEN
Deparaffinization and Rehydration
paraffin wax coated slide
116
Remove paraffin wax and hydrate tissue
section.
SPECIMEN
Deparaffinization and Rehydration
tissue section
117
SPECIMEN
LabVisionCorp.
NM-123
Coloncarcinoma
MS-1375CEA
3% hydrogen peroxide solution for 10 minutes to
inactivate endogenous peroxidase activity.
Deparaffinization and Rehydration
Block Endogenous Peroxidase
118
SPECIMEN
LabVisionCorp.
NM-123
Coloncarcinoma
MS-1375CEA
Rinse in distilled water and wash 2 times in
PBS buffer.
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Rinse
119
20:00
Microwave for 20 minutes using citrate
buffer solution pH 6.0.
Rinse
Antigen Retrieval
Deparaffinization and Rehydration
Block Endogenous Peroxidase
SPECIMEN
LabVisionCorp.
NM-123
Coloncarcinoma
MS-1375CEA
120
Thorough rinse in distilled water and wash 2
times in PBS buffer.
Rinse
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Rinse
SPECIMEN
121
3% bovine serum albumin (BSA) to block nonspecific staining.
Drain excess BSA after incubation.
Protein Block
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Rinse
Rinse
SPECIMEN
122
Optimally diluted CEA antibody for 30 minutes.
Primary Antibody
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Rinse
Rinse
SPECIMEN
123
Wash 2 times in PBS buffer.
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Rinse
Rinse
Rinse
SPECIMEN
124
Biotinylated link antibody for 10 minutes.
Biotinylated Secondary Antibody
Rinse
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Rinse
Rinse
SPECIMEN
125
Wash 2 times in PBS buffer.
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Biotinylated Secondary Antibody
Rinse
Rinse
Rinse
Rinse
SPECIMEN
126
HRP conjugated streptavidin for 10 minutes.
Deparaffinization and Rehydration
Streptavidin HRP
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Biotinylated Secondary Antibody
Rinse
Rinse
Rinse
Rinse
SPECIMEN
127
Wash 2 times in PBS buffer.
Deparaffinization and Rehydration
Streptavidin HRP
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Biotinylated Secondary Antibody
Rinse
Rinse
Rinse
Rinse
Rinse
SPECIMEN
128
AEC chromogen for 10 minutes.
AEC Chromogen
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Biotinylated Secondary Antibody
Streptavidin HRP
Rinse
Rinse
Rinse
Rinse
Rinse
SPECIMEN
129
SPECIMEN
Wash 2 times in PBS buffer and rinse in
distilled water.
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Biotinylated Secondary Antibody
Streptavidin HRP
AEC Chromogen
Rinse
Rinse
Rinse
Rinse
Rinse
Rinse
130
Counterstain in Mayer’s Hematoxylin for 1
minute.
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Biotinylated Secondary Antibody
Streptavidin HRP
AEC Chromogen
Rinse
Rinse
Rinse
Rinse
Rinse
Rinse
Hematoxylin Counterstain
SPECIMEN
131
SPECIMEN
Thorough wash in tap water to “blue” the nuclei.
Hematoxylin Counterstain
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Biotinylated Secondary Antibody
Streptavidin HRP
AEC Chromogen
Rinse
Rinse
Rinse
Rinse
Rinse
Rinse
Rinse
132
Coverslip using an aqueous mount.
Deparaffinization and Rehydration
Block Endogenous Peroxidase
Antigen Retrieval
Protein Block
Primary Antibody
Biotinylated Secondary Antibody
Streptavidin HRP
AEC Chromogen
Rinse
Rinse
Rinse
Rinse
Rinse
Rinse
Hematoxylin Counterstain
Rinse
Aqueous Mount
SPECIMEN
133
IHC Staining Patterns
134
Various staining patterns that can be achieved after
performing an IHC stain.
135
c-erbB-2
Breast carcinoma
AEC chromogen
CD3/T-Cell
Tonsil
AEC chromogen
136
Estrogen Receptor (ER)
Breast carcinoma
AEC chromogen
Cyclin D1
Mantle cell lymphoma
DAB chromogen
137
Keratin, Pan
Colon carcinoma
AEC chromogen
Vimentin
Melanoma
AEC chromogen
138
Hepatitis B Surface Antigen
(HBsAg)
Infected Liver
DAB chromogen
Hepatitis B Core Antigen
(HBcAg)
Infected Liver
AEC chromogen
139
Toxoplasma gondii
Infected Brain
AEC chromogen
Adenovirus
Infected Appendix
DAB chromogen
140
141

More Related Content

What's hot

Immunohistochemistry
Immunohistochemistry Immunohistochemistry
Immunohistochemistry
Atifa Ambreen
 
immunohistochemistry
immunohistochemistryimmunohistochemistry
immunohistochemistry
Snehadurugkar
 
An Introduction to Immunohistochemistry
An Introduction to ImmunohistochemistryAn Introduction to Immunohistochemistry
An Introduction to Immunohistochemistry
Creative-Bioarray
 
Immunohistochemistry
ImmunohistochemistryImmunohistochemistry
Immunohistochemistry
Saranraj P
 
Immunohistochemistry new
Immunohistochemistry newImmunohistochemistry new
Immunohistochemistry new
Shabab Ali
 
priciples and applications Immunohistochemistry
priciples and applications Immunohistochemistry priciples and applications Immunohistochemistry
priciples and applications Immunohistochemistry
Markos Tadele
 
Basics of Immunohistochemistry (IHC)
Basics of Immunohistochemistry (IHC)Basics of Immunohistochemistry (IHC)
Basics of Immunohistochemistry (IHC)
BioGenex
 
Immunohistochemistry
Immunohistochemistry Immunohistochemistry
Immunohistochemistry
ShahzebHUSSAIN5
 
Basics of Immunohistochemistry
Basics of Immunohistochemistry Basics of Immunohistochemistry
Basics of Immunohistochemistry
Jacob Lyons
 
Hla typing 2
Hla typing 2Hla typing 2
Hla typing 2
deepak deshkar
 
Immunohistochemistry
ImmunohistochemistryImmunohistochemistry
Immunohistochemistry
Creative-Bioarray
 
Immunohistochemistry
Immunohistochemistry Immunohistochemistry
Immunohistochemistry
Appy Akshay Agarwal
 
Immunofluorescence
ImmunofluorescenceImmunofluorescence
Immunofluorescence
Shilpy Singh
 
How To Optimize Your Immunohistochemistry Experiment
How To Optimize Your Immunohistochemistry ExperimentHow To Optimize Your Immunohistochemistry Experiment
How To Optimize Your Immunohistochemistry Experiment
Proteintech Group
 
An introduction to immunohistochemistry
An introduction to immunohistochemistryAn introduction to immunohistochemistry
An introduction to immunohistochemistry
Expedeon
 
Immunohistochemistry
ImmunohistochemistryImmunohistochemistry
Immunohistochemistry
JaandeepCheema
 
Antigen - antibody reactions.ppt
Antigen - antibody reactions.pptAntigen - antibody reactions.ppt
Antigen - antibody reactions.ppt
KrishnaAgarwal89691
 
1378968135.74359 immunohistochemistry
1378968135.74359  immunohistochemistry1378968135.74359  immunohistochemistry
1378968135.74359 immunohistochemistry
Debashree roy
 
Immunofluorescence and its role in histopathology
Immunofluorescence and its role in histopathologyImmunofluorescence and its role in histopathology
Immunofluorescence and its role in histopathology
MD Patholgoy, AFMC
 

What's hot (20)

Immunohistochemistry
Immunohistochemistry Immunohistochemistry
Immunohistochemistry
 
immunohistochemistry
immunohistochemistryimmunohistochemistry
immunohistochemistry
 
An Introduction to Immunohistochemistry
An Introduction to ImmunohistochemistryAn Introduction to Immunohistochemistry
An Introduction to Immunohistochemistry
 
Immunohistochemistry
ImmunohistochemistryImmunohistochemistry
Immunohistochemistry
 
Immunohistochemistry new
Immunohistochemistry newImmunohistochemistry new
Immunohistochemistry new
 
priciples and applications Immunohistochemistry
priciples and applications Immunohistochemistry priciples and applications Immunohistochemistry
priciples and applications Immunohistochemistry
 
Basics of Immunohistochemistry (IHC)
Basics of Immunohistochemistry (IHC)Basics of Immunohistochemistry (IHC)
Basics of Immunohistochemistry (IHC)
 
Immunohistochemistry
Immunohistochemistry Immunohistochemistry
Immunohistochemistry
 
Immunofluorescence
ImmunofluorescenceImmunofluorescence
Immunofluorescence
 
Basics of Immunohistochemistry
Basics of Immunohistochemistry Basics of Immunohistochemistry
Basics of Immunohistochemistry
 
Hla typing 2
Hla typing 2Hla typing 2
Hla typing 2
 
Immunohistochemistry
ImmunohistochemistryImmunohistochemistry
Immunohistochemistry
 
Immunohistochemistry
Immunohistochemistry Immunohistochemistry
Immunohistochemistry
 
Immunofluorescence
ImmunofluorescenceImmunofluorescence
Immunofluorescence
 
How To Optimize Your Immunohistochemistry Experiment
How To Optimize Your Immunohistochemistry ExperimentHow To Optimize Your Immunohistochemistry Experiment
How To Optimize Your Immunohistochemistry Experiment
 
An introduction to immunohistochemistry
An introduction to immunohistochemistryAn introduction to immunohistochemistry
An introduction to immunohistochemistry
 
Immunohistochemistry
ImmunohistochemistryImmunohistochemistry
Immunohistochemistry
 
Antigen - antibody reactions.ppt
Antigen - antibody reactions.pptAntigen - antibody reactions.ppt
Antigen - antibody reactions.ppt
 
1378968135.74359 immunohistochemistry
1378968135.74359  immunohistochemistry1378968135.74359  immunohistochemistry
1378968135.74359 immunohistochemistry
 
Immunofluorescence and its role in histopathology
Immunofluorescence and its role in histopathologyImmunofluorescence and its role in histopathology
Immunofluorescence and its role in histopathology
 

Viewers also liked

Indian habitat centre (6)
Indian habitat centre (6)Indian habitat centre (6)
Indian habitat centre (6)
tivar rose
 
India Habitat Center
India Habitat CenterIndia Habitat Center
India Habitat Center
Saumyadip Maiti
 
Indian habitat center mohammad zafar
Indian habitat center   mohammad zafarIndian habitat center   mohammad zafar
Indian habitat center mohammad zafar
Amity University, Noida
 
Joseph allen stein pro
Joseph allen stein proJoseph allen stein pro
Joseph allen stein prochunnuchauhan
 
Indian habitat center
Indian habitat centerIndian habitat center
Indian habitat center
Pukar Bhandari
 
Ihc case study ppt a3
Ihc case study ppt a3Ihc case study ppt a3
Ihc case study ppt a3Rohit Arora
 
Joseph allen stein
Joseph allen steinJoseph allen stein
Joseph allen steinTanvi Chadha
 

Viewers also liked (8)

Indian habitat centre (6)
Indian habitat centre (6)Indian habitat centre (6)
Indian habitat centre (6)
 
India Habitat Center
India Habitat CenterIndia Habitat Center
India Habitat Center
 
Indian habitat center mohammad zafar
Indian habitat center   mohammad zafarIndian habitat center   mohammad zafar
Indian habitat center mohammad zafar
 
Indian Habitat Centre
Indian Habitat CentreIndian Habitat Centre
Indian Habitat Centre
 
Joseph allen stein pro
Joseph allen stein proJoseph allen stein pro
Joseph allen stein pro
 
Indian habitat center
Indian habitat centerIndian habitat center
Indian habitat center
 
Ihc case study ppt a3
Ihc case study ppt a3Ihc case study ppt a3
Ihc case study ppt a3
 
Joseph allen stein
Joseph allen steinJoseph allen stein
Joseph allen stein
 

Similar to IHC

Immunochemical techniques]
Immunochemical techniques]Immunochemical techniques]
Immunochemical techniques]
Komal Kp
 
Polyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody productionPolyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody production
Dr. Amer Ali Khaleel /HMU
 
Monoclonal and Polyclonal Antibodies
Monoclonal and Polyclonal AntibodiesMonoclonal and Polyclonal Antibodies
Monoclonal and Polyclonal Antibodies
Rafat F Chowdhury
 
Immunity and its applied aspect
Immunity and its applied aspectImmunity and its applied aspect
Immunity and its applied aspect
DrRoopse Singh
 
Immunoassay( theoretical basis and optimization of immunoassay)
Immunoassay( theoretical basis and optimization of immunoassay)Immunoassay( theoretical basis and optimization of immunoassay)
Immunoassay( theoretical basis and optimization of immunoassay)
Rashmi116
 
Monoclonal and polyclonal antibody
Monoclonal and polyclonal antibodyMonoclonal and polyclonal antibody
Monoclonal and polyclonal antibody
Amjad Afridi
 
Lect. 12 Pl Path 502 Plant Virus Serology.pdf
Lect. 12 Pl Path 502 Plant Virus Serology.pdfLect. 12 Pl Path 502 Plant Virus Serology.pdf
Lect. 12 Pl Path 502 Plant Virus Serology.pdf
dawitg2
 
Introduction To Immunity and Immunological Products
Introduction To Immunity and Immunological ProductsIntroduction To Immunity and Immunological Products
Introduction To Immunity and Immunological Products
ISF COLLEGE OF PHARMACY MOGA
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
LAKSHMI DEEPTHI GEDELA
 
Antigen
Antigen Antigen
IHC LABEL.pptx
IHC LABEL.pptxIHC LABEL.pptx
IHC LABEL.pptx
MANJULRAJPUT1
 
12. Immunological techniques_MWM.pptx
12. Immunological techniques_MWM.pptx12. Immunological techniques_MWM.pptx
12. Immunological techniques_MWM.pptx
NayeemulIslam13
 
Nature of antigens
Nature of antigensNature of antigens
Nature of antigensYeyeh Santos
 
Monoclonal Antibodies
Monoclonal Antibodies Monoclonal Antibodies
Monoclonal Antibodies
IssahAbdulHananGiras
 
Monoclonal vs. Polyclonal Antibodies: Detail Exploration | The Lifesciences M...
Monoclonal vs. Polyclonal Antibodies: Detail Exploration | The Lifesciences M...Monoclonal vs. Polyclonal Antibodies: Detail Exploration | The Lifesciences M...
Monoclonal vs. Polyclonal Antibodies: Detail Exploration | The Lifesciences M...
The Lifesciences Magazine
 
Monoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringMonoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody Engineering
ARUNDHATI MEHTA
 
BASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptxBASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptx
malti19
 
BASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptxBASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptx
malti19
 

Similar to IHC (20)

Immunochemical techniques]
Immunochemical techniques]Immunochemical techniques]
Immunochemical techniques]
 
ODD for human blood-M. Asif
ODD for human blood-M. AsifODD for human blood-M. Asif
ODD for human blood-M. Asif
 
Polyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody productionPolyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody production
 
Monoclonal and Polyclonal Antibodies
Monoclonal and Polyclonal AntibodiesMonoclonal and Polyclonal Antibodies
Monoclonal and Polyclonal Antibodies
 
Immunity and its applied aspect
Immunity and its applied aspectImmunity and its applied aspect
Immunity and its applied aspect
 
MCAB
MCABMCAB
MCAB
 
Immunoassay( theoretical basis and optimization of immunoassay)
Immunoassay( theoretical basis and optimization of immunoassay)Immunoassay( theoretical basis and optimization of immunoassay)
Immunoassay( theoretical basis and optimization of immunoassay)
 
Monoclonal and polyclonal antibody
Monoclonal and polyclonal antibodyMonoclonal and polyclonal antibody
Monoclonal and polyclonal antibody
 
Lect. 12 Pl Path 502 Plant Virus Serology.pdf
Lect. 12 Pl Path 502 Plant Virus Serology.pdfLect. 12 Pl Path 502 Plant Virus Serology.pdf
Lect. 12 Pl Path 502 Plant Virus Serology.pdf
 
Introduction To Immunity and Immunological Products
Introduction To Immunity and Immunological ProductsIntroduction To Immunity and Immunological Products
Introduction To Immunity and Immunological Products
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Antigen
Antigen Antigen
Antigen
 
IHC LABEL.pptx
IHC LABEL.pptxIHC LABEL.pptx
IHC LABEL.pptx
 
12. Immunological techniques_MWM.pptx
12. Immunological techniques_MWM.pptx12. Immunological techniques_MWM.pptx
12. Immunological techniques_MWM.pptx
 
Nature of antigens
Nature of antigensNature of antigens
Nature of antigens
 
Monoclonal Antibodies
Monoclonal Antibodies Monoclonal Antibodies
Monoclonal Antibodies
 
Monoclonal vs. Polyclonal Antibodies: Detail Exploration | The Lifesciences M...
Monoclonal vs. Polyclonal Antibodies: Detail Exploration | The Lifesciences M...Monoclonal vs. Polyclonal Antibodies: Detail Exploration | The Lifesciences M...
Monoclonal vs. Polyclonal Antibodies: Detail Exploration | The Lifesciences M...
 
Monoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringMonoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody Engineering
 
BASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptxBASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptx
 
BASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptxBASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptx
 

More from DrShrikant Sonune

Artefacts in hemat part 2
Artefacts in hemat part 2Artefacts in hemat part 2
Artefacts in hemat part 2
DrShrikant Sonune
 
Artefaccts in hemat part 1
Artefaccts in hemat part 1Artefaccts in hemat part 1
Artefaccts in hemat part 1
DrShrikant Sonune
 
IHC
IHCIHC
Red lesion of oral mucosa
Red lesion of oral mucosa Red lesion of oral mucosa
Red lesion of oral mucosa
DrShrikant Sonune
 
4. midline diastema
4. midline diastema4. midline diastema
4. midline diastema
DrShrikant Sonune
 
3. noninvasive age estimation technique
3. noninvasive age estimation technique3. noninvasive age estimation technique
3. noninvasive age estimation technique
DrShrikant Sonune
 
1. angiokeratoma
1. angiokeratoma1. angiokeratoma
1. angiokeratoma
DrShrikant Sonune
 
H & e staining part 2
H & e staining part 2H & e staining part 2
H & e staining part 2
DrShrikant Sonune
 
H & e staining part 1
H & e staining part 1H & e staining part 1
H & e staining part 1
DrShrikant Sonune
 
Seminar part 2 salivary gland
Seminar part 2 salivary glandSeminar part 2 salivary gland
Seminar part 2 salivary gland
DrShrikant Sonune
 
H & e staining part 2
H & e staining part 2H & e staining part 2
H & e staining part 2
DrShrikant Sonune
 
H & E staining part 1
H & E staining part 1H & E staining part 1
H & E staining part 1
DrShrikant Sonune
 
Salivary glands -1
Salivary glands -1 Salivary glands -1
Salivary glands -1
DrShrikant Sonune
 
Fixation
Fixation Fixation
Oral epithelium
Oral epitheliumOral epithelium
Oral epithelium
DrShrikant Sonune
 
Epithelium in General
Epithelium in General Epithelium in General
Epithelium in General
DrShrikant Sonune
 

More from DrShrikant Sonune (16)

Artefacts in hemat part 2
Artefacts in hemat part 2Artefacts in hemat part 2
Artefacts in hemat part 2
 
Artefaccts in hemat part 1
Artefaccts in hemat part 1Artefaccts in hemat part 1
Artefaccts in hemat part 1
 
IHC
IHCIHC
IHC
 
Red lesion of oral mucosa
Red lesion of oral mucosa Red lesion of oral mucosa
Red lesion of oral mucosa
 
4. midline diastema
4. midline diastema4. midline diastema
4. midline diastema
 
3. noninvasive age estimation technique
3. noninvasive age estimation technique3. noninvasive age estimation technique
3. noninvasive age estimation technique
 
1. angiokeratoma
1. angiokeratoma1. angiokeratoma
1. angiokeratoma
 
H & e staining part 2
H & e staining part 2H & e staining part 2
H & e staining part 2
 
H & e staining part 1
H & e staining part 1H & e staining part 1
H & e staining part 1
 
Seminar part 2 salivary gland
Seminar part 2 salivary glandSeminar part 2 salivary gland
Seminar part 2 salivary gland
 
H & e staining part 2
H & e staining part 2H & e staining part 2
H & e staining part 2
 
H & E staining part 1
H & E staining part 1H & E staining part 1
H & E staining part 1
 
Salivary glands -1
Salivary glands -1 Salivary glands -1
Salivary glands -1
 
Fixation
Fixation Fixation
Fixation
 
Oral epithelium
Oral epitheliumOral epithelium
Oral epithelium
 
Epithelium in General
Epithelium in General Epithelium in General
Epithelium in General
 

Recently uploaded

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 

Recently uploaded (20)

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 

IHC

  • 1. 1 Presented by Dr. Shrikant Sonune Guided by Dr Ashok Patil, Dr Shilpa Kandalgaonkar, Dr Mayur Chaudhary, Dr Suyog Tupsakhare, Dr Mahesh Gabhane. Immunohistochemical technique (part I)
  • 2.  Histochemistry is a science that combines the techniques of biochemistry and histology in the study of the chemical constitution of tissues and cells.  Immunology is a science that deals with the immune system, cell-mediated and humoral aspects of immunity and immune responses.  Immunohistochemistry (IHC) is the integration of the above mentioned disciplines.
  • 3.  IHC utilizes antibodies and antibody based technology to detect and localize specific tissue antigens.  The basic principle of any IHC procedures is that an antibody will specifically bind with an antigen to produce an exclusive antibody-antigen complex.  This bonding is used to visualize both normal and diseased states of tissues.
  • 4.
  • 5.  An antigen is a foreign substance that stimulates antibody formation and has the ability to bind to an antibody.  Antigens are commonly proteins or glycoproteins of high molecular weight.  Usually produce antibodies when administrated parentally. (except some antigen like oral vaccines )
  • 6.  Specificity is hallmark of immunologic reaction.  2 attributes of antigenicity are 1. Introduction of immune response (immunogenicity) 2. Specific reaction with antibodies or sensitized cells (immunological reactivity)
  • 7.  Complete antigen  Haptens incapable of inducing antibody formation by themselves . It can become immunogenic when combine with larger molecule carrier.
  • 8.  The site on an antigen to which a complementary antibody may specifically react is called an epitope or antigenic determinant.(considered as smallest unit of antigenicity) 7 surface of the antigenepitope antibody
  • 9.  Consist of 4 to 5 amino acids  Possessing  Specific chemical structure  Electric charge  Special configuration  Capable of sensitizing immunocytes
  • 10.  May having primary sequence (linear epitope), tertiary structure(folded structure).  T –cells recognize sequential epitope.  B- cells recognize tertiary epitope.  The combining area on the antibody molecule is called Paratopes
  • 11.  An antibody is an immunoglobulin (Ig) capable of specific combination with the antigen that caused its production.  They are produced by plasma cells as a protection from invasion of foreign substances such as bacteria, viruses, etc.  Antibodies are formed from plasma cells .
  • 12.  Proteins of animal origin endowed with known antibody activity & for certain other proteins related to them by chemical structure.  Synthesize by plasma cells & to some extent by lymphocytes  Immunoglobulin provides a structural & chemical concept  While antibody is biological & functional concept.
  • 13.  Each antibody consists of four polypeptides – two identical heavy chains and two identical light chains joined to form a "Y" shaped molecule. 9 heavy chains light chains
  • 14.  The classic Y shape of the antibody is composed of two variable antigen-specific Fab “arms” and the constant Fc “tail”. Fab 10 Fc
  • 15.  The amino acid sequence in the tips of the “arms" varies among different antibodies. This variable region gives the antibody its specificity for binding antigen. variable region 11
  • 16.
  • 17.  The constant region determines the mechanism used to destroy antigen.  Antibodies are divided into five major classes based on this region’s structure and immune function. 12 constant region
  • 18.  Antibodies can be divided into five major classes depending on the structure of h-chain.  The light chains of any antibody can be classified as either a kappa or lambda type based on small polypeptide structural differences. Immunoglobulin class H- chains IgG γ (gamma) IgA α (alpha) IgM µ (mu ) IgD (delta ) IgE (epsilon)
  • 19.  The most commonly used antibody in IHC is of the IgG class.  Because it is the major class of immunoglobulin released in serum.
  • 20.  Major serum immunoglobulin  80% of total  Distributed equally in intravascular & extra vascular compartments.  Less carbohydrates  Half life app 23 days  Provides passive natural immunity in newborn.
  • 21.  Sub-classes of IgG IgG1 65 IgG2 23 IgG3 8 IgG4 4
  • 22.  Second most abundant class.  10 -13 %  .6 – 4.2 mg / ml  Half life 6 – 8 days  2types Secretory IgA Serum IgA
  • 24.  Antibodies bind to antigen through the variable regions of the antibody.  This bonding may be hydrophobic, ionic, Van der Waals or hydrogen bonding.  The strength of the binding of an antibody to a specific antigen is called affinity.  High affinity antibodies will bind larger amounts of antigen in a given period of time, and can be used at higher dilutions. 16
  • 25.  The rate of antigen-antibody reaction is affected by  temperature  pH of buffers  diluents used in IHC procedures.  Higher incubation temperature permits rapid antigen- antibody binding.  The buffer’s pH and ionic content can affect the charge of amino acids in both the antibody and antigen. 17
  • 26. 18
  • 27.  Antibodies are generated by immunizing (injecting) animals with purified antigen.  The animal responds by producing antibodies that specifically recognize and bind to the antigen.  Antibody reagents may be polyclonal or monoclonal. 19
  • 29.  Polyclonal antibody reagents are produced as different classes of immunoglobulins by many B-cells clones and react with various epitopes on an antigen.  They are more tolerant of small changes in the nature of the antigen since they often recognize multiple epitopes.  They may be generated in a variety of animals like rabbit, goat, sheep, horse, etc.  The rabbit is the most commonly used animal for generating polyclonal antibodies. 21
  • 30. 22 Polyclonal antibodies reacting with various epitopes Each antibody is made by a different B-cell
  • 32. A rabbit is injected (intradermally or subcutaneously) with a purified dose of antigen. 24 antigen
  • 33. The rabbit’s immune system responds by producing antibodies specific to the injected antigen. 25 Y Y Y antibodies
  • 34. Blood is harvested from the ear at the peak of antibody production. 26
  • 35. Red blood cells and clotting proteins are removed and the antiserum is purified. Y Y Y Y Y Y 27
  • 36.  Polyclonal antibodies are purified either by Protein Purification or Antigen Affinity Chromatography.  Protein Purification eliminates the bulk of serum proteins but does not eliminate nonspecific immunoglobulin fraction.  Antigen Affinity Purification eliminates the bulk of the nonspecific immunoglobulin fraction using antigen to capture the antibody leaving only the immunoglobulin of desired specificity. 28
  • 38.  Monoclonal antibodies are derived from a single B-cell and are produced as a single class of immunoglobulin.  They are raised by fusion of the specific B-cells with immortal myeloma (B-cell) cancer cells to form a hybridoma.  A hybridoma can multiply indefinitely and continuously produce a specific monoclonal antibody.  They react with a specific epitope on a given antigen, giving less background staining. 30
  • 39.  Because they react with only one epitope, they are more vulnerable to the loss of epitope through chemical treatment of the antigen (e.g., fixation). 31
  • 40. Monoclonal antibodies reacting with similar epitopes 32
  • 42. A mouse is injected (intradermally or subcutaneously) with a purified dose of antigen. antigen 34
  • 43. The mouse’s immune system responds by producing antibodies specific to the injected antigen. Y Y Y antibodies 35
  • 44. The antibody-producing B-cells are harvested from the spleen or lymph nodes. B-lymphocytes spleen 36
  • 45. The B-cells are fused with mouse myeloma cells forming immortal hybrid cells or hybridomas. myeloma cells 37 B-lymphocytes
  • 46. The generated hybridomas will produce many copies of the exact same antibody. 38
  • 47. The hybridomas are either transplanted into the peritoneal cavity of a syngeneic mouse and the antibodies produced are harvested as ascitic fluid. 39
  • 48. Or are propagated in a tissue culture medium and the antibodies produced are harvested as a hybridoma supernatant 40
  • 50.  Primary antibody refers to the antibody that is directed against the antigen of interest.  For example, CD20 can be used as the primary antibody to demonstrate B-cells on a tissue section.  Both polyclonal and monoclonal antibodies can be used as primaries.  They are typically supplied by manufacturers in two formats: concentrated or ready-to-use (RTU). 42
  • 51.  Manufacturers usually provide the user with a recommended dilution range for concentrated antibodies.  Concentrated antibodies are more economical to use but has a disadvantage of requiring time and effort in initially determining the optimal dilution.  Ready To Use antibodies are convenient but the cost is significantly greater than that of diluted concentrated antibodies. 43
  • 52. Antibody Titer and Dilution 44
  • 53.  Titer is the highest dilution of the antibody resulting in strong specific staining with the least amount of background.  Background includes all nonspecific staining as a result of procedural artifacts.  Dilution is the ratio of the concentrated antibody to the total volume of the desired.  For example, a 1:5 dilution means one part concentrated antibody and four parts diluent.  Optimal working dilution is typically determined by titration or dilution series. 45
  • 55. At 1:50, the Islet cells stain strongly but there is also a strong background staining. 1:50 background staining Islet cells 48
  • 56. At 1:800, there is no background staining but the Islet cells stain very weak. 1:800 49
  • 57. At 1:200, there is good contrast and no background staining, it is therefore the optimal working dilution. 1:200 50
  • 59.  Incubation time is inversely proportional to antibody concentration.  Higher concentration of antibody allows shorter incubation time.  It can be from minutes to hours, with 30-60 minutes the most common practice. 52
  • 61.  Antibody-antigen reaction is hastened at 37C as compared to room temperature.  An increase in temperature also allows for a higher dilution of the antibody.  Humidity chambers must be used when incubating at higher temperature to prevent drying of tissue sections. 54
  • 63.  During the process of formalin fixation, many antigenic sites are ‘masked’ and are therefore sometimes difficult or impossible to stain without antigen retrieval.  Antigen retrieval is a process of treating formalin fixed- paraffin embedded tissue sections with proteolytic enzymes or heating them in various buffer solutions in order to expose the antigen.  Commonly used proteolytic enzymes include trypsin, pepsin and protease. 56
  • 64.  Heat induced epitope retrieval (HIER) includes microwaving, pressure cooking, steaming, autoclaving.  Requires buffer of different concentrations and pH. Commonly used buffers include  Citrate at pH 6.0  EDTA at pH 8.0  Tris-HCL at pH 10.0 57
  • 65. The staining results of CD3 antibody on tonsil, with and without antigen retrieval. No Antigen RetrievalCitrate buffer, pH 6.0 58
  • 67.  Enzymes are proteins that act as catalysts to increase the rate of chemical reaction.  Detection systems attach enzyme labels to primary or secondary antibodies to visualize the localized antibody- antigen binding in tissue section. 60
  • 68.  They are used in IHC to convert a colorless reagent into a stable colored product (chromogen) that marks the site of antibody-antigen complex.  A chromogen is a substance that absorbs light, producing color.
  • 69.  Commonly used enzyme labels for IHC procedures include  horseradish peroxidase (HRP)  alkaline phophatase (AP)  HRP, from horseradish plant, is an enzyme that catalyze the reduction of hydrogen peroxide (H2O2) to water and oxygen.  Commonly used chromogens for HRP include  Amino ethylcarbazole (AEC)  Diaminobenzidine (DAB) 61
  • 70.  Amino ethylcarbazole is oxidized by HRP producing a bright red reaction product.  This reaction product is not stable and may fade over time. 62
  • 71.  Amino ethylcarbazole is soluble in alcohol,  Stained slides should therefore be counterstained with non-alcoholic hematoxylins (Mayer’s or Gills). 63
  • 72.  Diaminobenzidine is oxidized by HRP producing a dark brown reaction product.  This reaction product is stable and does not fade over time. 64
  • 73.  Diaminobenzidine stained slides can be coverslipped with permanent organic based mounting media.  In some IHC procedures, the dark brown reaction product can be modified and intensified by adding metals (copper or cobalt) to Diaminobenzidine solution.  Diaminobenzidine is not suited for staining melanoma cases because the endogenous dark brown pigments in tumor cells can be confused with DAB reaction product. 65
  • 74. Staining results using AEC and Diaminobenzidine chromogens. AEC chromogen Melanoma DAB chromogen Melanoma 66
  • 75.
  • 77. The various IHC staining methods which can be used to localize tissue antigens for light microscopy. 68
  • 78.  Direct Method  Two-Step Indirect Method  Three-Step Indirect Method  Peroxidase-Antiperoxidase (PAP) Method  Alkaline-Antialkaline Phosphatase (APAAP) Method  Avidin-Biotin Complex (ABC) Method  Labeled Streptavidin-Biotin (LSAB) Method 69
  • 80.  This method uses an enzyme-labeled primary antibody with known antigenic specificity.  Enzymes such as horseradish peroxidase (HRP) and alkaline phosphatase (AP) are either conjugated to the primary antibody.  Less sensitive compared to other methods because it produces little signal since only one enzyme-labeled antibody is involved. 71
  • 81.  Although rarely used nowadays, it has the advantages of rapidity, ease of performance and limited nonspecific reaction.  Mostly used in fluorescent techniques where the primary antibody is labeled with fluorescent compound (e.g., fluorescein isothiocyanate . 72
  • 82. An enzyme-labeled primary antibody binds to the tissue antigen. 73 enzyme primary Ab antigen
  • 83. A substrate-chromogen solution is added producing a colored end-product. 74 substrate-chromogen
  • 85.  Uses an enzyme-labeled secondary antibody that is directed against the unlabeled primary antibody.  If the primary antibody (which is now the antigen) is made in mouse, the secondary antibody must be against mouse immunoglobulin.  More sensitive than the Direct Method because several secondary antibodies are likely to bind with a number of various epitopes on the primary antibody increasing the enzyme labels involved. 76
  • 86. An unlabeled primary antibody binds to the tissue antigen. 77 primary Ab (mouse) antigen
  • 87. An enzyme-labeled secondary antibody binds to the primary antibody. 78 secondary Ab (rabbit anti-mouse) enzyme
  • 88. A substrate-chromogen solution is added producing a colored end-product. 79 substrate-chromogen
  • 89.  Only one secondary antibody is shown bound to the primary antibody in the previous illustration.  However, several secondary antibodies are likely to bind with various epitopes on the primary antibody, thus increasing the signal. 80
  • 91.  Uses another layer of enzyme-labeled (tertiary) antibody that is added to the previously described Two-Step Indirect Method.  The added antibody layer increases signal and staining intensity that is helpful when staining antigens with few or limited available epitopes.  Both secondary and tertiary antibodies must be conjugated to the same enzyme. 82
  • 92. An unlabeled primary antibody binds to the tissue antigen. 83 antigen primary Ab (mouse)
  • 93. An enzyme-labeled secondary antibody binds to the primary antibody. 84 secondary Ab (rabbit anti-mouse) enzyme
  • 94. An enzyme-labeled tertiary antibody is added and binds to the secondary antibody. 85 tertiary Ab (goat anti-rabbit)
  • 95. A substrate-chromogen solution is added producing a colored end-product. 86 substrate- chromogen substrate- chromogen
  • 96.  Only one secondary antibody is shown bound to the primary antibody in the previous illustration.  However, several secondary antibodies are likely to bind with different epitopes on the primary antibody, thus increasing the signal. 87
  • 98.  These methods are among the sensitive IHC techniques, attributed to more enzyme molecules being localized per antigenic site.  Methods include  peroxidase-antiperoxidase (PAP)  alkaline phosphatase-antialkaline phosphatase (APAAP)  The secondary antibody must be directed against both the primary and the antibody of the enzyme-antienzyme immune complex. 89
  • 99.  Preformed soluble enzyme-antienzyme immune complex is prepared by mixing excess enzyme to its antibody. 90 antienzymeenzymes enzyme-antienzyme immune complex
  • 100.  The PAP immune complex consists of three molecules of peroxidase and two antibodies.  The APAAP immune complex consists of two molecules of alkaline phosphatase and one antibody. 91 peroxidase-antiperoxidase complex alkaline phosphatase-antialkaline phosphatase complex
  • 102. An unlabeled primary antibody binds to the tissue antigen. 94 primary Ab (mouse) antigen
  • 103. A secondary antibody binds to the primary antibody. 95 secondary Ab (rabbit anti-mouse)
  • 104. A horseradish peroxidase- mouse-antiperoxidase complex is added and is bound by the secondary antibody. 96 enzyme-antienzyme immune complex
  • 105. A substrate-chromogen solution is added producing a colored end-product. 97 substrate-chromogen
  • 106.  Only one secondary antibody is shown bound to the primary antibody in the previous illustration. However, several secondary antibodies are likely to bind with different epitopes on the primary antibody, thus increasing the signal. 98
  • 108.  Uses the strong and high affinity of avidin (egg white glycoprotein) for biotin (water-soluble vitamin).  Avidin has four binding sites for biotin but fewer than four molecules of biotin will actually bind to avidin. 100 avidin biotin molecules
  • 109.  Two of the most common methods include  Avidin-Biotin enzyme Complex (ABC)  Labeled StreptAvidin-Biotin (LSAB)  The inherent amplification of sensitivity offered by avidin and biotin makes these methods more favorable than PAP or APAAP.  Streptavidin, a bacterial protein has recently replaced avidin because it produces less background staining than avidin. 101
  • 111.  The enzyme complex is prepared by mixing biotinylated enzyme (HRP ) and avidin. avidin-biotin-enzyme complex 103  This preformed avidin-biotin-enzyme complex then reacts with the biotinylated secondary antibody. avidinbiotinylated enzyme
  • 112. An unlabeled primary antibody binds to the antigen. 104 antigen primary Ab (mouse)
  • 113. A biotinylated secondary antibody binds to the primary antibody. 105 secondary Ab (rabbit anti-mouse) biotin
  • 114. A preformed avidin-biotin-enzyme complex solution is added and binds to the biotinylated secondary antibody. 106 avidin-biotin-enzyme complex
  • 115. A substrate-chromogen solution is added ending the reaction and producing a colored end-product. 107 substrate- chromogen substrate- chromogen
  • 117.  Uses enzyme-conjugated streptavidin. Streptavidin is conjugated to several molecules of enzyme horseradish peroxidase (HRP) or alkaline phosphatase (AP).  The secondary antibody is conjugated to numerous biotin molecules, each of which can potentially bind to an enzyme-conjugated streptavidin. 109
  • 118. An unlabeled primary antibody binds to tissue antigen. 110 antigen primary Ab
  • 119. A biotinylated secondary antibody binds to the primary antibody. Each secondary antibody contains multiple biotin molecules; several secondary antibodies can bind to the primary antibody. 111 biotin secondary Ab
  • 120. An enzyme-labeled streptavidin is added and binds to the secondary antibody. HRP-streptavidin 112
  • 121. A substrate-chromogen solution is added producing a colored end-product. substrate- chromogen 113
  • 122. 114
  • 123. Remove paraffin wax and hydrate tissue section. SPECIMEN Deparaffinization and Rehydration paraffin wax coated slide 116
  • 124. Remove paraffin wax and hydrate tissue section. SPECIMEN Deparaffinization and Rehydration tissue section 117
  • 125. SPECIMEN LabVisionCorp. NM-123 Coloncarcinoma MS-1375CEA 3% hydrogen peroxide solution for 10 minutes to inactivate endogenous peroxidase activity. Deparaffinization and Rehydration Block Endogenous Peroxidase 118
  • 126. SPECIMEN LabVisionCorp. NM-123 Coloncarcinoma MS-1375CEA Rinse in distilled water and wash 2 times in PBS buffer. Deparaffinization and Rehydration Block Endogenous Peroxidase Rinse 119
  • 127. 20:00 Microwave for 20 minutes using citrate buffer solution pH 6.0. Rinse Antigen Retrieval Deparaffinization and Rehydration Block Endogenous Peroxidase SPECIMEN LabVisionCorp. NM-123 Coloncarcinoma MS-1375CEA 120
  • 128. Thorough rinse in distilled water and wash 2 times in PBS buffer. Rinse Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Rinse SPECIMEN 121
  • 129. 3% bovine serum albumin (BSA) to block nonspecific staining. Drain excess BSA after incubation. Protein Block Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Rinse Rinse SPECIMEN 122
  • 130. Optimally diluted CEA antibody for 30 minutes. Primary Antibody Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Rinse Rinse SPECIMEN 123
  • 131. Wash 2 times in PBS buffer. Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Rinse Rinse Rinse SPECIMEN 124
  • 132. Biotinylated link antibody for 10 minutes. Biotinylated Secondary Antibody Rinse Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Rinse Rinse SPECIMEN 125
  • 133. Wash 2 times in PBS buffer. Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Biotinylated Secondary Antibody Rinse Rinse Rinse Rinse SPECIMEN 126
  • 134. HRP conjugated streptavidin for 10 minutes. Deparaffinization and Rehydration Streptavidin HRP Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Biotinylated Secondary Antibody Rinse Rinse Rinse Rinse SPECIMEN 127
  • 135. Wash 2 times in PBS buffer. Deparaffinization and Rehydration Streptavidin HRP Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Biotinylated Secondary Antibody Rinse Rinse Rinse Rinse Rinse SPECIMEN 128
  • 136. AEC chromogen for 10 minutes. AEC Chromogen Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Biotinylated Secondary Antibody Streptavidin HRP Rinse Rinse Rinse Rinse Rinse SPECIMEN 129
  • 137. SPECIMEN Wash 2 times in PBS buffer and rinse in distilled water. Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Biotinylated Secondary Antibody Streptavidin HRP AEC Chromogen Rinse Rinse Rinse Rinse Rinse Rinse 130
  • 138. Counterstain in Mayer’s Hematoxylin for 1 minute. Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Biotinylated Secondary Antibody Streptavidin HRP AEC Chromogen Rinse Rinse Rinse Rinse Rinse Rinse Hematoxylin Counterstain SPECIMEN 131
  • 139. SPECIMEN Thorough wash in tap water to “blue” the nuclei. Hematoxylin Counterstain Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Biotinylated Secondary Antibody Streptavidin HRP AEC Chromogen Rinse Rinse Rinse Rinse Rinse Rinse Rinse 132
  • 140. Coverslip using an aqueous mount. Deparaffinization and Rehydration Block Endogenous Peroxidase Antigen Retrieval Protein Block Primary Antibody Biotinylated Secondary Antibody Streptavidin HRP AEC Chromogen Rinse Rinse Rinse Rinse Rinse Rinse Hematoxylin Counterstain Rinse Aqueous Mount SPECIMEN 133
  • 142. Various staining patterns that can be achieved after performing an IHC stain. 135
  • 144. Estrogen Receptor (ER) Breast carcinoma AEC chromogen Cyclin D1 Mantle cell lymphoma DAB chromogen 137
  • 145. Keratin, Pan Colon carcinoma AEC chromogen Vimentin Melanoma AEC chromogen 138
  • 146. Hepatitis B Surface Antigen (HBsAg) Infected Liver DAB chromogen Hepatitis B Core Antigen (HBcAg) Infected Liver AEC chromogen 139
  • 147. Toxoplasma gondii Infected Brain AEC chromogen Adenovirus Infected Appendix DAB chromogen 140
  • 148. 141